Progress in vaccine roll-out last fall contrasts with waning public trust, largely due to challenges in accessing RSV vaccines. However, COVID-19-related hospitalizations have surged since November. By mid-December 2023, the CDC reported a nationwide increase in flu cases, despite vaccination falling short of 2022’s total by 8 million.<\/p>\n\n\n\n
The US is navigating its first respiratory viral season since the pandemic, with an uptick in flu, COVID-19, and Respiratory Syncytial Virus (RSV) cases.<\/p>\n\n\n\n
Now media have raised the spectre of a potential ‘triple-threat’ epidemic.<\/p>\n\n\n\n
Last fall saw the US reviewing its infectious disease control plans in the wake of the COVID-19 pandemic. Newly-developed jabs targeting RSV were in circulation, and upgraded COVID-19 vaccines<\/a> were also rolled out.<\/p>\n\n\n\n But public confidence is falling due to difficulty in accessing the RSV vaccine, while the take-up rate for the updated COVID-19 vaccines remains low.<\/p>\n\n\n\n COVID-19 hospitalization figures have risen since last November. Testing of domestic waste water shows significantly-increased viral concentrations in nearly 69 percent of locations.<\/p>\n\n\n\n The Centers for Disease Control and Prevention (CDC) has reported a widespread increase in flu cases nationwide. By mid-December there was a notable decline in flu vaccine uptake, with approximately 8 million fewer individuals vaccinated than in 2022.<\/p>\n\n\n\n During the initial pandemic phases, stringent measures to curb COVID-19 transmission seemingly also suppressed flu infections, which almost diappeared.. However, the subsequent 2022-23 flu season indicated a resurgence of flu cases.<\/p>\n\n\n\n According to a KFF survey<\/a>, only about 20 percent of American adults have received the latest COVID-19 vaccine shot. Similarly, the adoption of earlier vaccine versions appeared lackluster, indicating that many individuals might still lack protection from the initial immunizations in 2020 or 2021.<\/p>\n\n\n\n Dr Luis Ostrosky from UTHealth Houston and Memorial Hermann spoke to media about the simultaneous increases in flu and COVID-19, highlighting a steady yet troubling uptick in RSV cases in the Houston area of Texas.<\/p>\n\n\n\n Underlining the severity of the situation, the CDC issued a health alert in late December 2023 urging clinicians to prioritize vaccinations and timely testing for patients exhibiting symptoms.<\/p>\n\n\n\n